Ying Xian1, Eric E Smith, Xin Zhao, Eric D Peterson, DaiWai M Olson, Adrian F Hernandez, Deepak L Bhatt, Jeffrey L Saver, Lee H Schwamm, Gregg C Fonarow. 1. From the Duke Clinical Research Institute, Durham, NC (Y.X., X.Z., E.D.P., A.F.H.); Department of Clinical Neurosciences and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada (E.E.S.); Department of Neurology & Neurotherapeutics, Neurological Surgery, University of Texas Southwestern Medical Center, Dallas (D.M.O.); Department of Neurology, University of California, Los Angeles (J.L.S.); Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (D.L.B.); Stroke Service, Massachusetts General Hospital, Boston (L.H.S.); and Division of Cardiology, University of California, Los Angeles (G.C.F.).
Abstract
BACKGROUND AND PURPOSE: The benefits of intravenous tissue-type plasminogen activator in acute ischemic stroke are time dependent, and several strategies have been reported to be associated with more rapid door-to-needle (DTN) times. However, the extent to which hospitals are using these strategies and their association with DTN times have not been well studied. METHODS: We surveyed 304 Get With The Guidelines-Stroke hospitals joining TARGET: Stroke regarding their baseline use of strategies to reduce DTN times in the January 2008 to December 2009 time frame before the initiation of TARGET: Stroke and determined the association between hospital strategies and DTN times. RESULTS: Among 5460 patients receiving tissue-type plasminogen activator within 3 hours of symptom onset in surveyed hospitals, the median DTN time was 72 minutes (interquartile range, 55-94). Reported use of the different strategies varied considerably. Of 11 hospital strategies analyzed individually by multivariable analysis, 3 strategies were independently associated with shorter DTN times. These included rapid triage/stroke team notification (209/304 [69%] hospitals, 8.1-minute reduction in DTN time), single-call activation system (190/304 [63%] hospitals, 4.3 minutes), and tissue-type plasminogen activator stored in the emergency department (189/304 [62%] hospitals, 3.5 minutes). When analyzed incrementally, hospitals that used a greater number of strategies had shorter DTN times with 1.3 minutes (adjusted mean difference) saved for each strategy implemented (14 minutes if all strategies were used). CONCLUSIONS: Although the majority of participating hospitals reported using some strategy to reduce delays in tissue-type plasminogen activator administration for acute ischemic stroke, the strategies applied vary considerably and those most strongly associated with shorter DTN times were applied relatively less frequently.
BACKGROUND AND PURPOSE: The benefits of intravenous tissue-type plasminogen activator in acute ischemic stroke are time dependent, and several strategies have been reported to be associated with more rapid door-to-needle (DTN) times. However, the extent to which hospitals are using these strategies and their association with DTN times have not been well studied. METHODS: We surveyed 304 Get With The Guidelines-Stroke hospitals joining TARGET: Stroke regarding their baseline use of strategies to reduce DTN times in the January 2008 to December 2009 time frame before the initiation of TARGET: Stroke and determined the association between hospital strategies and DTN times. RESULTS: Among 5460 patients receiving tissue-type plasminogen activator within 3 hours of symptom onset in surveyed hospitals, the median DTN time was 72 minutes (interquartile range, 55-94). Reported use of the different strategies varied considerably. Of 11 hospital strategies analyzed individually by multivariable analysis, 3 strategies were independently associated with shorter DTN times. These included rapid triage/stroke team notification (209/304 [69%] hospitals, 8.1-minute reduction in DTN time), single-call activation system (190/304 [63%] hospitals, 4.3 minutes), and tissue-type plasminogen activator stored in the emergency department (189/304 [62%] hospitals, 3.5 minutes). When analyzed incrementally, hospitals that used a greater number of strategies had shorter DTN times with 1.3 minutes (adjusted mean difference) saved for each strategy implemented (14 minutes if all strategies were used). CONCLUSIONS: Although the majority of participating hospitals reported using some strategy to reduce delays in tissue-type plasminogen activator administration for acute ischemic stroke, the strategies applied vary considerably and those most strongly associated with shorter DTN times were applied relatively less frequently.
Entities:
Keywords:
quality improvement; quality of health care; stroke
Authors: Michael J Ward; Sean P Collins; Jesse M Pines; Curt Dill; Gary Tyndall; Chad S Kessler Journal: Am J Emerg Med Date: 2015-04-06 Impact factor: 2.469
Authors: Shreyansh Shah; Marie Luby; Karen Poole; Teresa Morella; Elizabeth Keller; Richard T Benson; John K Lynch; Zurab Nadareishvili; Amie W Hsia Journal: Neurology Date: 2015-05-13 Impact factor: 9.910
Authors: Xin Tong; Jennifer L Wiltz; Mary G George; Erika C Odom; Sallyann M Coleman King; Tiffany Chang; Xiaoping Yin; Robert K Merritt Journal: Circ Cardiovasc Qual Outcomes Date: 2018-12
Authors: Soraya Hengsawas Surasarang; Sawittree Sahakijpijarn; Galina Florova; Andrey A Komissarov; Christina L Nelson; Enkhbaatar Perenlei; Satoshi Fukuda; Marla R Wolfson; Thomas H Shaffer; Steven Idell; Robert O Williams Journal: J Drug Deliv Sci Technol Date: 2018-04-30 Impact factor: 3.981
Authors: Jessalyn K Holodinsky; Amy Y X Yu; Zarina A Assis; Abdulaziz S Al Sultan; Bijoy K Menon; Andrew M Demchuk; Mayank Goyal; Michael D Hill Journal: Curr Neurol Neurosci Rep Date: 2016-05 Impact factor: 5.081
Authors: Sara K Rostanski; Joshua I Stillman; Lauren R Schaff; Crismely A Perdomo; Ava L Liberman; Eliza C Miller; Randolph S Marshall; Joshua Z Willey; Olajide Williams Journal: Neurohospitalist Date: 2017-01-17
Authors: Ganesh Asaithambi; Amy L Castle; Michael A Sperl; Jayashree Ravichandran; Aditi Gupta; Bridget M Ho; Sandra K Hanson Journal: Neurohospitalist Date: 2017-04-16